Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125431561 | 12543156 | 1 | I | 20150901 | 20160519 | 20160711 | 20160711 | EXP | DE-ROCHE-1761464 | ROCHE | 12.68 | YR | M | Y | 47.90000 | KG | 20160711 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125431561 | 12543156 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 400 | MG | |||||||||
| 125431561 | 12543156 | 2 | SS | Tocilizumab | TOCILIZUMAB | 1 | 125276 | ||||||||||||
| 125431561 | 12543156 | 3 | SS | CANAKINUMAB | CANAKINUMAB | 1 | Intravenous (not otherwise specified) | 0 | 150 | MG | |||||||||
| 125431561 | 12543156 | 4 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 0 | 500 | MG | QD | ||||||||
| 125431561 | 12543156 | 5 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 0 | 60 | MG | |||||||||
| 125431561 | 12543156 | 6 | C | PREDNISON | PREDNISONE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 125431561 | 12543156 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 1 | DF | /wk | ||||||||
| 125431561 | 12543156 | 8 | C | METAMIZOL | METAMIZOLE SODIUM | 1 | Oral | 0 | 500 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125431561 | 12543156 | 1 | Juvenile idiopathic arthritis |
| 125431561 | 12543156 | 2 | Juvenile idiopathic arthritis |
| 125431561 | 12543156 | 3 | Juvenile idiopathic arthritis |
| 125431561 | 12543156 | 4 | Juvenile idiopathic arthritis |
| 125431561 | 12543156 | 6 | Juvenile idiopathic arthritis |
| 125431561 | 12543156 | 7 | Juvenile idiopathic arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125431561 | 12543156 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125431561 | 12543156 | Abdominal pain upper | |
| 125431561 | 12543156 | Faecal calprotectin increased | |
| 125431561 | 12543156 | Juvenile idiopathic arthritis | |
| 125431561 | 12543156 | Sudden hearing loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125431561 | 12543156 | 1 | 20150601 | 20160111 | 0 | |
| 125431561 | 12543156 | 3 | 20160208 | 0 | ||
| 125431561 | 12543156 | 4 | 20150601 | 0 | ||
| 125431561 | 12543156 | 5 | 201602 | 0 | ||
| 125431561 | 12543156 | 6 | 20150601 | 0 | ||
| 125431561 | 12543156 | 7 | 20070801 | 20090901 | 0 | |
| 125431561 | 12543156 | 8 | 201602 | 0 |